Functional Outcomes After Rectal ESD: A Retrospective Evaluation of Low Anterior Resection Syndrome
Journal of Surgical Oncology · 2025
DOI: 10.1002/jso.70115 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2025. Verfasst von Fevzi Cengiz und 4 weiteren Autor:innen. Beteiligte Einrichtung: General Surgery, Izmir Katip Celebi University, İzmir, Turkey. Hauptthemen laut MEDLINE: Rectal Neoplasms, Endoscopic Mucosal Resection, Postoperative Complications. Die Arbeit nennt 12 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Objective
Endoscopic submucosal dissection (ESD) is increasingly preferred as an alternative to surgery and as an organ‐preserving method for the treatment of rectal lesions. However, its impact on bowel function—particularly the development of low anterior resection syndrome (LARS)—remains poorly understood. This study aimed to evaluate the incidence of LARS following rectal ESD and to identify associated clinical and pathological factors.
Methods
Data from 118 patients who underwent rectal ESD between January 2018 and December 2024 were retrospectively analyzed. Demographic characteristics, lesion location and size, histopathological findings, and LARS scores were recorded. All procedures were performed by the same experienced colorectal surgeon. For functional assessment, patients were contacted by telephone, and the LARS score was administered.
Results
Of the patients included in the study, 60.9% were male, with a mean age of 68.2 ± 11.0 years. In total, 93.2% of lesions were located in the rectum, while 6.8% were located in the anal canal or anorectal junction. The mean lesion size was 5.04 ± 3.19 cm. Lymphovascular invasion was detected in four patients. Minor LARS was observed in 3.4% ( n = 4) of cases, and no cases of major LARS were identified. All patients with LARS had adenomas located in the lower rectum containing high‐grade dysplasia.
Conclusion
The incidence of LARS after rectal ESD is low and limited to minor symptoms. Lesion location, size, and dysplasia grade may influence LARS development. These findings support ESD as a functionally safe treatment approach. Further validation in larger, prospective studies is warranted. Trial Registration This study was a retrospective observational analysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- General Surgery, Izmir Katip Celebi University, İzmir, Turkey.
- Department of General Surgery, Medicana International İzmir Hospital, İzmir, Turkey.
- Department of General Surgery, İzmir Katip Çelebi University, İzmir, Turkey.
- General Surgery, Sultan Abdulhamid Han Educational and Research Hospital, Istanbul, Turkey.
ORCID-Profile: Fevzi Cengiz, Süleyman Günay, Sezgin Vatansever, Nurhilal Kızıltoprak, Saadet Koca
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Cengiz, F., Günay, S., Vatansever, S., Kızıltoprak, N., & Koca, S. (2025). Functional Outcomes After Rectal ESD: A Retrospective Evaluation of Low Anterior Resection Syndrome. Journal of Surgical Oncology. https://doi.org/10.1002/jso.70115
Vancouver
Cengiz F, Günay S, Vatansever S, Kızıltoprak N, Koca S. Functional Outcomes After Rectal ESD: A Retrospective Evaluation of Low Anterior Resection Syndrome. Journal of Surgical Oncology. 2025. doi:10.1002/jso.70115
BibTeX
@article{Cengiz2025,
author = {Cengiz, Fevzi and Günay, Süleyman and Vatansever, Sezgin and Kızıltoprak, Nurhilal and Koca, Saadet},
title = {Functional Outcomes After Rectal ESD: A Retrospective Evaluation of Low Anterior Resection Syndrome},
journal = {Journal of Surgical Oncology},
year = {2025},
doi = {10.1002/jso.70115}
}
EUVIMED